Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Unienzyme** is a digestive enzyme supplement tablet manufactured primarily by Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd, used to treat indigestion, flatulence, bloating, gas, heartburn, abdominal discomfort, and related gastrointestinal issues. It contains **fungal diastase** (a starch-degrading enzyme that breaks down carbohydrates into simpler sugars), **papain** (a proteolytic enzyme from papaya that hydrolyzes proteins to aid digestion), and **activated charcoal** (an adsorbent that binds intestinal gases and toxins to reduce bloating and flatulence). The combination neutralizes excess stomach acid, removes toxic wastes from the GI tract, and supports overall digestive health, with additional reported benefits for hangover relief, bile flow issues in pregnancy, and stomach poisoning.[1][2][3][7][13]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Unienzyme.